4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-083071
CEO & President sold 4,060 shares at $13.35 ($54,201)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cox John CEO & President | 2025-06-05 | Sale 10b5-1 | −4,060 | $13.35 | $54,201 | 142,179 | D |
| Open-market sales · 4,060 sh · avg $13.35 · $54,201 | |||||||
Loading xslF345X05/ownership.xml…